Microbix Biosystems (TSE:MBX) Stock Crosses Above 50-Day Moving Average – Should You Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$0.23 and traded as high as C$0.26. Microbix Biosystems shares last traded at C$0.23, with a volume of 106,000 shares changing hands.

Microbix Biosystems Price Performance

The company has a market capitalization of C$32.56 million, a P/E ratio of -7.83 and a beta of 0.40. The business’s 50-day moving average is C$0.23 and its two-hundred day moving average is C$0.24. The company has a quick ratio of 5.57, a current ratio of 7.51 and a debt-to-equity ratio of 30.47.

Microbix Biosystems (TSE:MBX) last issued its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$4.22 million during the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%. As a group, analysts predict that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

About Microbix Biosystems

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.